439 related articles for article (PubMed ID: 34824452)
1. Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design.
Malone B; Urakova N; Snijder EJ; Campbell EA
Nat Rev Mol Cell Biol; 2022 Jan; 23(1):21-39. PubMed ID: 34824452
[TBL] [Abstract][Full Text] [Related]
2. Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus.
Sevajol M; Subissi L; Decroly E; Canard B; Imbert I
Virus Res; 2014 Dec; 194():90-9. PubMed ID: 25451065
[TBL] [Abstract][Full Text] [Related]
3. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.
Savastano A; Ibáñez de Opakua A; Rankovic M; Zweckstetter M
Nat Commun; 2020 Nov; 11(1):6041. PubMed ID: 33247108
[TBL] [Abstract][Full Text] [Related]
4. Replication of the coronavirus genome: A paradox among positive-strand RNA viruses.
Grellet E; L'Hôte I; Goulet A; Imbert I
J Biol Chem; 2022 May; 298(5):101923. PubMed ID: 35413290
[TBL] [Abstract][Full Text] [Related]
5. Cellular host factors for SARS-CoV-2 infection.
Baggen J; Vanstreels E; Jansen S; Daelemans D
Nat Microbiol; 2021 Oct; 6(10):1219-1232. PubMed ID: 34471255
[TBL] [Abstract][Full Text] [Related]
6. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.
Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J
Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611
[TBL] [Abstract][Full Text] [Related]
7. A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses.
Ahn DG; Yoon GY; Lee S; Ku KB; Kim C; Kim KD; Kwon YC; Kim GW; Kim BT; Kim SJ
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452503
[TBL] [Abstract][Full Text] [Related]
8. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
[TBL] [Abstract][Full Text] [Related]
9. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
10. SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro.
van Hemert MJ; van den Worm SH; Knoops K; Mommaas AM; Gorbalenya AE; Snijder EJ
PLoS Pathog; 2008 May; 4(5):e1000054. PubMed ID: 18451981
[TBL] [Abstract][Full Text] [Related]
11. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
[TBL] [Abstract][Full Text] [Related]
12. The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2.
Ziv O; Price J; Shalamova L; Kamenova T; Goodfellow I; Weber F; Miska EA
Mol Cell; 2020 Dec; 80(6):1067-1077.e5. PubMed ID: 33259809
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome.
Bhatt PR; Scaiola A; Loughran G; Leibundgut M; Kratzel A; Meurs R; Dreos R; O'Connor KM; McMillan A; Bode JW; Thiel V; Gatfield D; Atkins JF; Ban N
Science; 2021 Jun; 372(6548):1306-1313. PubMed ID: 34029205
[TBL] [Abstract][Full Text] [Related]
14. [RNA polymerase: The Achilles heel of SARS-CoV-2].
Corteggiani M; Gombert L; Pellegri C; Aussel L
Med Sci (Paris); 2021 Mar; 37(3):288-292. PubMed ID: 33739278
[No Abstract] [Full Text] [Related]
15. Replication-transcription complex of coronaviruses: functions of individual viral non-structural subunits, properties and architecture of their complexes.
Mishchenko EL; V A Ivanisenko VA
Vavilovskii Zhurnal Genet Selektsii; 2022 Mar; 26(2):121-127. PubMed ID: 35434485
[TBL] [Abstract][Full Text] [Related]
16. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
[TBL] [Abstract][Full Text] [Related]
17. MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity.
Wang L; Sola I; Enjuanes L; Zuñiga S
mBio; 2021 Oct; 12(5):e0131621. PubMed ID: 34517762
[TBL] [Abstract][Full Text] [Related]
18. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics.
Smith EC; Blanc H; Surdel MC; Vignuzzi M; Denison MR
PLoS Pathog; 2013 Aug; 9(8):e1003565. PubMed ID: 23966862
[TBL] [Abstract][Full Text] [Related]
19. A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex.
Eydoux C; Fattorini V; Shannon A; Le TT; Didier B; Canard B; Guillemot JC
J Virol Methods; 2021 Feb; 288():114013. PubMed ID: 33166547
[TBL] [Abstract][Full Text] [Related]
20. Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread.
Ambike S; Cheng CC; Feuerherd M; Velkov S; Baldassi D; Afridi SQ; Porras-Gonzalez D; Wei X; Hagen P; Kneidinger N; Stoleriu MG; Grass V; Burgstaller G; Pichlmair A; Merkel OM; Ko C; Michler T
Nucleic Acids Res; 2022 Jan; 50(1):333-349. PubMed ID: 34928377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
